[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_97":98},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":29,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":57,"_58":57,"_59":60,"_61":40,"_62":63},"id","dq17z3m0wel8i2vste3q1xvkc","revision",2,"title","Marex Group 发行挂钩 QQQ 与 SPY 较差表现者的杠杆票据","originalTitle","Marex Group Ltd (0001997464) (Filer)","summary","Marex Group Limited 提交定价补充文件，发行总额 355,000 美元、每份本金 1,000 美元的杠杆票据，挂钩 Invesco QQQ Trust 与 SPDR S&P 500 ETF Trust 中表现较差者，期限约 1.5 年。","reason","source",{"_11":87,"_88":89,"_90":91,"_92":57,"_93":94,"_95":96},"links",{"_84":85,"_63":86},"publishedAt","2026-10-28T14:55:12.000Z","discoveredAt","2026-10-28T15:21:43.601Z","timelineAt","category","ai-products","tags",[81,82,83],"stockSymbols",[80],"score",22,"selected",false,"channel","news","story",{"_72":73,"_15":74},"x","readingMode","full","author","language","body",{"_76":-5,"_63":77,"_78":-5,"_79":40},"outline",[],"relatedStories",[75],"indexable",true,"markdownAvailable","group",{"_64":65,"_43":66,"_67":68,"_69":70,"_71":70},"hasTranslation","bodyLanguage","original","factId","f31fKOIY_mNE",{"_72":73,"_15":74},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","5702e85b-d23e-403b-b1da-b50da29e7487","Marex发行挂钩QQQ与SPY较差表现者的杠杆票据",{"_72":73,"_15":74},"zh","

Filed Pursuant to Rule 424(b)(2)

Registration No. 333-289203

$\"\"$

Pricing Supplement dated October 27, 2026

(To\nETF Underlying Supplement dated July 6, 2026, Prospectus Supplement dated July 6, 2026, and Prospectus dated July 6, 2026)

Marex\nGroup Limited

$355,000\nLeveraged Notes Linked to the Worst Performing of the Invesco QQQ Trust^SM, Series 1 and the State Street^® SPDR^®\nS&P 500^® ETF Trust due May 2, 2028

►	1.50x\n upside exposure to any increases in the price of the worst performing of the Invesco QQQ\n Trust^SM, Series 1 and the State Street^® SPDR^® S&P\n 500^® ETF Trust

►	Return\n of principal if the price of the Worst Performing Underlying does not change

►	1-to-1\n downside exposure to any decrease in the price of the Worst Performing Underlying and in\n such a case, you will lose some or all of your Principal Amount

\n\n\n

►	Term:\n Approximately 1.5 years

\n\n

►

All\n payments on the Notes are subject to the credit risk of Marex Group Limited (“Marex”)

Application\nhas been made for the Leveraged Notes (the “Notes”) offered hereunder to be admitted to listing and trading on the Vienna\nMultilateral Trading Facility (“Vienna MTF”) of the Vienna Stock Exchange. The Vienna MTF is not a regulated market as defined\nby Directive 2014/65/EU (as amended, “MiFID II”). It is, however, a multilateral trading facility (MTF) for purposes of MiFID\nII.

Neither\nthe U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of\nthe Notes or passed upon the accuracy or the adequacy of this document or the accompanying prospectus, prospectus supplement or underlying\nsupplement. Any representation to the contrary is a criminal offense.

Any\noffering of the Notes will be made pursuant to Article 1(4) of Regulation (EU) 2017/1129 (as amended), including as it forms part of\ndomestic law of the United Kingdom. Accordingly, no prospectus is required to be published in connection with such offering of the Notes\nin any member state of the European Economic Area (the “EEA”) or the United Kingdom (the “UK”). See page ii of\nthe accompanying prospectus supplement for further restrictions on offers and sales of the Notes in the EEA and the UK.

Investment\nin the Notes involves certain risks. You should refer to “Risk Factors” beginning on page PS-7 of this document, page S-1\nof the accompanying prospectus supplement and page S-1 of the accompanying underlying supplement.

The\nEstimated Initial Value of the Notes on the Trade Date is $996.00 per Note, which is less than the price to public. The market value\nof the Notes at any time will reflect many factors and cannot be predicted with accuracy. See “Summary—Estimated Initial\nValue” on page PS-3 and “Risk Factors” beginning on page PS-7 of this document for additional information.

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

	Price\n to Public	Underwriting\n Discount ⁽¹⁾	Proceeds\n to Issuer
Per\n Note	$1,000.00	$2.50	$997.50
Total	$355,000.00	$887.50	$354,112.50

⁽¹⁾\nMarex Capital Markets Inc. (“MCMI”), an affiliate of ours, will act as the agent for the sale of the Notes. MCMI will purchase\nthe Notes from us at an underwriting discount of $2.50 per $1,000 Principal Amount for distribution to other registered broker-dealers\nor will offer the Notes directly to investors. MCMI will use the underwriting discount to pay selling concessions or fees (including\ncustodial or clearing fees) to other registered broker-dealers. See “Supplemental Plan of Distribution (Conflicts of Interest)”\non page PS-13 of this document.

The\nNotes:

\n \n \n \n \n

Are\n Not FDIC Insured

Are\n Not Bank Guaranteed

May\n Lose Value

Marex\nCapital Markets

SUMMARY

The\ninformation in this “Summary” section is qualified by the more detailed information set forth in the underlying supplement,\nthe prospectus supplement and the prospectus. See “General” in this document.

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

Issuer:	Marex\n Group Limited
Principal\n Amount:	$1,000\n per Note
Reference\n Asset:	The\n worst performing of the Invesco QQQ Trust℠,\n Series 1 (Bloomberg symbol : QQQ) (the “QQQ”) and the State Street^® SPDR^® S&P\n 500^® ETF Trust (Bloomberg symbol : SPY) (the “SPY”) (each, an “Underlying” and together,\n the “Underlyings”)
Pricing\n Date:	October\n 27, 2026
Trade\n Date:	October\n 27, 2026
Original\n Issue Date:	October\n 30, 2026
Final\n Valuation Date:	April\n 27, 2028, subject to adjustment as described under\n “Additional Terms of the Notes―Valuation Dates” in the accompanying underlying\n supplement.
Maturity\n Date:	May\n 2, 2028, subject to adjustment as described under\n “Additional Terms of the Notes―Interest Payment\n Dates, Coupon Payment Dates, Call Payment Dates and Maturity Date” in the accompanying underlying supplement.
Payment\n at Maturity:	For\n each $1,000 Principal Amount, you will receive a cash payment on the Maturity Date, calculated as follows: \n \n ■\n If the Reference Return of the Worst Performing Underlying\n is greater than zero: \n \n $1,000\n + ($1,000 × Reference Return of the Worst Performing Underlying × Upside Participation Rate) \n \n ■\n If the Reference Return of the Worst Performing Underlying\n is equal to or less than zero: \n \n $1,000\n + ($1,000 × Reference Return of the Worst Performing Underlying). \n \n In\n this case, you will lose 1% of the Principal Amount of your Notes for each percentage point that the Reference Return of the Worst\n Performing Underlying is below zero. For example, if the Reference Return of the Worst Performing Underlying is -50.00%, you will\n suffer a 50% loss and receive 50% of the Principal Amount, subject to the credit risk of Marex. If the Reference Return of the\n Worst Performing Underlying is negative, you will lose some or all of your investment. \n
Upside\n Participation Rate	150%\n (1.50x)
Worst\n Performing Underlying:	The\n Underlying with the lowest Reference Return.
Reference\n Return:	With\n respect to each Underlying, the quotient, expressed as a percentage, calculated as follows: \n \n Final\n Value – Initial Value \n Initial\n Value \n
Initial\n Value:	$721.25\n with respect to the QQQ and $769.66 with respect to the SPY, each of which was its Closing Price on the Pricing Date, subject to\n adjustment as described under “Additional Terms of the Notes—Anti-Dilution Adjustments” in the underlying supplement.
Final\n Value:	With\n respect to each Underlying, its Closing Price on the Final Valuation Date.
CUSIP/ISIN:	56653C4J1\n / US56653C4J19
Form\n of Notes:	Book-Entry
Listing:	Application\n has been made for the Notes to be admitted to listing and trading on the Vienna MTF, a multilateral trading facility operated by\n the Vienna Stock Exchange.

PS-2

\n \n \n \n \n \n \n

Estimated\n Initial Value:

The\n Estimated Initial Value of the Notes is less than the price you pay to purchase the Notes. The Estimated Initial Value does not represent\n a minimum price at which we or any of our affiliates would be willing to purchase your Notes in the secondary market, if any, at\n any time. See “Risk Factors — The Estimated Initial Value of the Notes, which was determined by us on the Trade Date,\n is less than the price to public and may differ from the market value of the Notes in the secondary market, if any.”

Calculation\n Agent:

Marex\n Financial, one of our affiliates

PS-3

GENERAL

This\ndocument relates to an offering of Notes linked to the Underlyings. The purchaser of a Note will acquire a senior unsecured debt security\nof Marex. Although the offering of Notes relates to the Underlyings, you should not construe that fact as a recommendation as to the\nmerits of acquiring an investment linked to the Underlyings or any securities held by any Underlying or as to the suitability of an investment\nin the Notes.

You\nshould read this document together with the prospectus dated July 6, 2026 (the “prospectus”), the prospectus supplement dated\nJuly 6, 2026 (the “prospectus supplement”) and the ETF Underlying Supplement dated July 6, 2026 (the “underlying supplement”).\nIf the terms of the Notes offered hereby are inconsistent with those described in the accompanying prospectus, prospectus supplement\nor underlying supplement, the terms described in this document shall control. You should carefully consider, among other things, the\nmatters set forth in “Risk Factors” beginning on page PS-7 of this document, page S-1 of the prospectus supplement and page\nS-1 of the underlying supplement, as the Notes involve risks not associated with conventional debt securities. We urge you to consult\nyour investment, legal, tax, accounting and other advisors before you invest in the Notes. As used herein, references to the “Issuer”,\n“Marex”, “we”, “us” and “our” are to Marex Group Limited. References to “Fund”\nor “Worst Performing Fund” in the underlying supplement will be references to “Underlying” or “Worst Performing\nUnderlying” in this document. Certain terms used but not defined herein will have the meanings set forth in the underlying supplement,\nthe prospectus supplement or the prospectus.

You\nmay access the underlying supplement, the prospectus supplement and the prospectus on the SEC website www.sec.gov as follows (or if such\naddress has changed, by reviewing our filing for the relevant date on the SEC website):

►

The\n underlying supplement at: https://www.sec.gov/Archives/edgar/data/1997464/000119312526295611/d157500d424b2.htm

►

The\n prospectus supplement at: https://www.sec.gov/Archives/edgar/data/1997464/000119312526295582/d135207d424b2.htm

►

The\n prospectus at: https://www.sec.gov/Archives/edgar/data/1997464/000119312526295577/d124247d424b3.htm

PS-4

PAYMENT\nON THE NOTES

Payment\nat Maturity

On\nthe Maturity Date, for each $1,000 Principal Amount of the Notes, we will pay you the Payment at Maturity, which is an amount in cash,\ncalculated as follows:

\n\n\n

	■	If\n the Reference Return of the Worst Performing Underlying is greater than zero:

$1,000\n+ ($1,000 × Reference Return of the Worst Performing Underlying × Upside Participation Rate)

\n\n\n

	■	If\n the Reference Return of the Worst Performing Underlying is equal to or less than zero:

$1,000\n+ ($1,000 × Reference Return of the Worst Performing Underlying).

In\nthis case, you will lose 1% of the Principal Amount of your Notes for each percentage point that the Reference Return of the Worst Performing\nUnderlying is below zero. For example, if the Reference Return of the Worst Performing Underlying is -50.00%, you will suffer a 50% loss\nand receive 50% of the Principal Amount, subject to the credit risk of Marex. If the Reference Return of the Worst Performing Underlying\nis negative, you will lose some or all of your investment.

Interest

The\nNotes will not pay interest.

PS-5

INVESTOR\nSUITABILITY

The\nNotes may be suitable for you if:

►

You\n are a retail investor outside the EEA and the UK or an institutional buyer (for restrictions\n on offers or sales to retail investors in the EEA and the UK, please see page ii of the accompanying\n prospectus supplement).

►

You\n are an investor with the competence (either independently or with the support of a financial\n advisor) to assess the suitability of this investment based on your individual circumstances.

►

You\n have the necessary knowledge and/or experience with structured products and are prepared\n to accept the corresponding risks.

►

You\n seek an investment with an enhanced return linked to the potential positive performance of\n the Worst Performing Underlying and you believe that the value of the Worst Performing Underlying\n will increase sufficiently over the term of the Notes.

►

You\n are willing to make an investment that is exposed to the potential downside performance of\n the Worst Performing Underlying on a 1-to-1 basis.

►

You\n are willing to lose up to 100% of the Principal Amount.

►

You\n understand that the return on the Notes will depend solely on the performance of the Worst\n Performing Underlying and consequently, the Notes are riskier than alternative investments\n linked to only one of the Underlyings or linked to a basket composed of the Underlyings.

►

You\n are willing to forgo the dividends or other distributions paid on an Underlying or the securities\n held by an Underlying.

►

You\n do not seek current income from your investment.

►

You\n are willing to hold the Notes to maturity.

►

You\n do not seek an investment for which there will be an active secondary market.

►

You\n are willing to accept the risk and return profile of the Notes versus a conventional debt\n security with a comparable maturity issued by Marex or another issuer with a similar credit\n rating.

►

You\n are comfortable with the creditworthiness of Marex, as Issuer of the Notes.

The\nNotes may not be suitable for you if:

►

You\n are a retail investor in the EEA or the UK (for restrictions on offers or sales to retail\n investors in the EEA and the UK, please see page ii of the accompanying prospectus supplement).

►

You\n are an investor without the competence (either independently or with the support of a financial\n advisor) to assess the suitability of this investment based on your individual circumstances.

►

You\n do not have the necessary knowledge and/or experience with structured products and are not\n prepared to accept the corresponding risks.

►

You\n believe that the Reference Return of the Worst Performing Underlying will be negative or\n it will not be sufficiently positive to provide you with your desired return.

►

You\n are unwilling to make an investment that is exposed to the potential downside performance\n of the Worst Performing Underlying on a 1-to-1 basis.

►

You\n seek an investment that provides full return of principal.

►

You\n seek exposure to a basket composed of the Underlyings or a similar investment in which the\n overall return is based on a blend of the performances of the Underlyings, rather than solely\n on the Worst Performing Underlying.

►

You\n prefer to receive the dividends or other distributions paid on an Underlying or the securities\n held by an Underlying.

►

You\n seek current income from your investment.

►

You\n are unable or unwilling to hold the Notes to maturity.

►

You\n seek an investment for which there will be an active secondary market.

►

You\n prefer the lower risk, and therefore accept the potentially lower returns, of conventional\n debt securities with comparable maturities issued by Marex or another issuer with a similar\n credit rating.

►

You\n are not willing or are unable to assume the credit risk associated with Marex, as Issuer\n of the Notes.

PS-6

RISK\nFACTORS

We\nurge you to read the section “Risk Factors” beginning on page S-1 of the accompanying prospectus supplement and page S-1\nof the accompanying underlying supplement. You should understand the risks of investing in the Notes and should reach an investment decision\nonly after careful consideration, with your advisors, of the suitability of the Notes in light of your particular financial circumstances\nand the information set forth in this document and the accompanying prospectus, prospectus supplement and underlying supplement.

In\naddition to the risks discussed below, you should review “Risk Factors” in the accompanying prospectus supplement and underlying\nsupplement, including the explanation of risks relating to the Notes described in the following sections:

► \n“—Risks Related to Note Issuances”\nin the prospectus supplement; and

► \n“—General risks related to a Fund”\nin the underlying supplement.

You\nwill be subject to significant risks not associated with conventional fixed-rate or floating-rate debt securities.

Risks\nRelating to the Structure or Features of the Notes

You\nmay lose some or all of the principal at maturity.

The\nNotes do not guarantee any return of principal. The Notes differ from ordinary debt securities in that we will not pay you 100% of the\nPrincipal Amount of your Notes if the Reference Return of the Worst Performing Underlying is negative. In this case, the Payment at Maturity\nyou will be entitled to receive will be less than the Principal Amount and you will lose 1% for each 1% that the Reference Return of\nthe Worst Performing Underlying is less than 0.00%. You may lose up to 100% of your investment at maturity.

The\namount payable on the Notes is not linked to the prices of the Underlyings at any time other than on the Final Valuation Date.

The\nFinal Value will be the Closing Prices of the Underlyings on the Final Valuation Date, subject to postponement for non-trading days and\ncertain Market Disruption Events. Even if the value of each Underlying increases during the term of the Notes other than on the Final\nValuation Date but then decreases on the Final Valuation Date to a value that is less than its Initial Value, the Payment at Maturity\nwill be less, possibly significantly less, than it would have been had the payment on the Notes been linked to the prices of the Underlyings\nother than such decrease. Although the actual prices of the Underlyings on the Maturity Date or at other times during the term of the\nNotes may be higher than the Closing Prices of the Underlyings on the Final Valuation Date, the payment on the Notes will be based solely\non the Closing Prices of the Underlyings on the Final Valuation Date.

The\nNotes are subject to the full risks of the Worst Performing Underlying and will be negatively affected if any Underlying performs poorly,\neven if the other Underlying performs favorably.

You\nare subject to the full risks of the Worst Performing Underlying. If the Worst Performing Underlying performs poorly, you will be negatively\naffected, even if the other Underlying performs favorably. The Notes are not linked to a basket composed of the Underlyings, where the\nbetter performance of one Underlying could offset the poor performance of the others. Instead, you are subject to the full risks of the\nWorst Performing Underlying on the Final Valuation Date. As a result, the Notes are riskier than an alternative investment linked to\nonly one of the Underlyings or linked to a basket composed of the Underlyings. You should not invest in the Notes unless you understand\nand are willing to accept the full downside risks of the Worst Performing Underlying.

The\nNotes will not bear interest.

As\na holder of the Notes, you will not receive interest payments.

Risks\nRelating to the Reference Asset

The\nNotes are subject to risks associated with non-U.S. companies.

Some\nof the equity securities held by the QQQ are issued by non-U.S. companies. Investments in securities linked to the value of such non-U.S.\nequity securities, such as the Notes, involve risks associated with the home countries of the issuers of those non-U.S. equity securities.\nThe prices of securities in non-U.S. markets may be affected by political, economic, financial and social factors in those countries,\nor global regions, including changes in government, economic and fiscal policies and currency exchange laws. These factors may adversely\naffect the performance of the QQQ and, as a result, the return on the Notes.

The\nperformance of an Underlying may not correlate with the performance of its underlying assets as well as the net asset value per share\nof that Underlying, especially during periods of market volatility.

The\nperformance of an Underlying and that of its underlying assets generally will vary due to, for example, transaction costs, management\nfees, certain corporate actions, and timing variances. Moreover, it is also possible that the performance of an Underlying may not fully\nreplicate or may, in certain circumstances, diverge significantly from the performance of its underlying assets. This could be due to,\nfor example, an Underlying holding assets that are not related to the underlying assets, the temporary unavailability of certain assets\nin the secondary market, the performance of any derivative instruments held by an Underlying, differences in trading hours between an\nUnderlying and the underlying assets, or due to other circumstances. This variation in performance is called the “tracking error,”\nand, at times, the tracking error may be significant.

PS-7

In\naddition, because the shares of an Underlying are traded on a securities exchange and are subject to market supply and investor demand,\nthe market price of one share of that Underlying may differ from its NAV per share; shares of an Underlying may trade at, above, or below\nits NAV per share.

During\nperiods of market volatility, certain assets held by an Underlying may be unavailable in the secondary market, market participants may\nbe unable to calculate accurately the NAV per share of that Underlying and the liquidity of that Underlying may be adversely affected.\nThis kind of market volatility may also disrupt the ability of market participants to create and redeem shares of an Underlying. Further,\nmarket volatility may adversely affect, sometimes materially, the prices at which market participants are willing to buy and sell shares\nof an Underlying. As a result, under these circumstances, the market value of shares of an Underlying may vary substantially from the\nNAV per share of an Underlying.

For\nthe foregoing reasons, the performance of an Underlying may not match the performance of its underlying assets over the same period.\nBecause of this variance, the return on the Notes, to the extent dependent on the performance of an Underlying, may not be the same as\nan investment directly in the securities, commodities, or other assets held by an Underlying or the same as a debt security with a return\nlinked to the performance of such underlying assets.

General\nRisk Factors

The\nNotes are subject to our credit risk.

Marex\nmay partially or wholly fail to meet their obligations under the Notes. Investors should therefore take the creditworthiness of Marex\nand its subsidiaries into account in their investment decision. Credit risk means the risk of insolvency or illiquidity of an issuer,\ni.e. a potential, temporary or final inability to fulfil their interest and repayment obligations on time. An increased insolvency risk\nis typical of issuers that have a low creditworthiness. The payment of any amount due on the Notes is subject to the credit risk of Marex.\nThe Notes are senior unsecured debt obligations of Marex, and are not, either directly or indirectly, an obligation of any third party.\nInvestors are dependent on Marex’s ability to pay all amounts due on the Notes, and therefore investors are subject to the credit\nrisk of Marex and to changes in the market’s view of its creditworthiness

The\nNotes are not bank deposits and are not insured or guaranteed by the U.S. Federal Deposit Insurance Corporation, the UK Financial Services\nCompensation Scheme or any other government or governmental or private agency or deposit protection scheme in any jurisdiction. Investors\nare dependent on Marex’s ability to pay all amounts due on the Notes, and therefore investors are subject to Marex’s credit\nrisk and to changes in the market’s view of Marex’s creditworthiness. The payment of any amount due on the Notes is not guaranteed\nby any entity.

The\nNotes are not insured against loss by any third parties; you can depend only on our earnings and assets for any payment on the Notes.

The\nNotes will be solely our obligations, and no other entity will have any obligation, contingent or otherwise, to make any payments in\nrespect of the Notes.

The\nEstimated Initial Value of the Notes, which was determined by us on the Trade Date, is less than the price to public and may differ from\nthe market value of the Notes in the secondary market, if any.

The\nEstimated Initial Value of the Notes was calculated by us on the Trade Date and is less than the price to public. The Estimated Initial\nValue reflects our and our affiliates’ internal funding rate, which is the borrowing rate paid to issue market-linked securities,\nas well as the mid-market value of the embedded derivatives in the Notes. This internal funding rate is typically lower than the rate\nwe would use when we issue conventional fixed or floating rate debt securities. As a result of the difference between our internal funding\nrate and the rate we would use when we issue conventional fixed or floating rate debt securities, the Estimated Initial Value of the\nNotes may be lower if it were based on the prices at which our fixed or floating rate debt securities trade in the secondary market.\nIn addition, if we were to use the rate we use for our conventional fixed or floating rate debt issuances, we would expect the economic\nterms of the Notes to be more favorable to you. We determined the value of the embedded derivatives in the Notes by reference to our\nor our affiliates’ internal pricing models. These pricing models consider certain assumptions and variables, which can include\nvolatility and interest rates. Different pricing models and assumptions could provide valuations for the Notes that are different from\nour Estimated Initial Value. These pricing models rely in part on certain forecasts about future events, which may prove to be incorrect.\nThe Estimated Initial Value does not represent a minimum price at which we or any of our affiliates would be willing to purchase your\nNotes in the secondary market (if any exists) at any time.

The\nprice of your Notes in the secondary market, if any, immediately after the Trade Date is expected to be less than the price to public.

The\nprice to public takes into account certain costs. These costs include our affiliates’ projected hedging profits (which may or may\nnot be realized) for assuming risks inherent in hedging our obligations under the Notes, the underwriting discount and the costs associated\nwith structuring and hedging our obligations under the Notes. These costs will be used or retained by us or one of our affiliates, except\nfor underwriting discounts paid to unaffiliated distributors. If you were to sell your Notes in the secondary market, if any, the price\nyou would receive for your Notes may be less than the price you paid for them because secondary market prices will not take into account\nthese costs. The price of your Notes in the secondary market, if any, at any time after issuance will vary based on many factors, including\nthe prices of the Underlyings and changes in market conditions, and cannot be predicted with accuracy. The Notes are not designed to\nbe short-term trading instruments, and you should, therefore, be able and willing to hold the Notes to maturity. Any sale of the Notes\nprior to maturity could result in a loss to you.

PS-8

If\nwe were to repurchase your Notes immediately after the Original Issue Date, the price you receive may be higher than the Estimated Initial\nValue of the Notes.

Assuming\nthat all relevant factors remain constant after the Original Issue Date, the price at which MCMI may initially buy or sell the Notes\nin the secondary market, if any, and the value that may initially be used for customer account statements, if any, may exceed the Estimated\nInitial Value on the Trade Date for a temporary period expected to be approximately 6 months after the Original Issue Date. This temporary\nprice difference may exist because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated\ncost of hedging our obligations under the Notes and other costs in connection with the Notes that we will no longer expect to incur over\nthe term of the Notes. We will make such discretionary election and determine this temporary reimbursement period on the basis of a number\nof factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated\ncosts which we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we\nmay discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Original Issue Date of the\nNotes based on changes in market conditions and other factors that cannot be predicted.

You\nwill not have any ownership interest in any Underlying or any securities held by any Underlying.

As\na holder of the Notes, you will not have any ownership interest in any Underlying or any securities held by any Underlying, such as rights\nto vote, dividend payments or other distributions. Because the return on the Notes will not reflect any dividends on any Underlying or\nany securities held by any Underlying, the Notes may underperform an investment in one or more Underlyings or the securities held by\nany Underlying.

The\nNotes lack liquidity.

The\nNotes are a new issue of securities for which there is no established market. Although we will apply for the Notes to be listed for trading\non the Vienna MTF, we cannot provide you with any assurance regarding whether the Notes will become or remain listed or whether a trading\nmarket for the Notes will develop or as to the liquidity or sustainability of any such market, the ability of holders of the Notes to\nsell their Notes or the price at which holders may be able to sell their Notes. The listing application will be subject to approval by\nthe Vienna Stock Exchange. There can be no assurance that application for listing and admission to trading will be granted or that an\nactive trading market in the Notes will develop. If such a listing is obtained, we have no obligation to maintain such listing, and we\nmay delist the Notes at any time. In addition, MCMI is not required to offer to purchase the Notes in the secondary market. Even if a\nsecondary market were to develop, it may not provide enough liquidity to allow you to trade or sell the Notes easily. Because other dealers\nare not likely to make a secondary market for the Notes, the price at which you may be able to trade your Notes is likely to depend on\nthe price, if any, at which MCMI is willing to buy the Notes.

Potential\nconflicts of interest may exist.

Marex\nand its affiliates play a variety of roles in connection with the issuance of the Notes, including acting as calculation agent and hedging\nour obligations under the Notes. Following the occurrence of certain events – relating to the Issuer, the Issuer's hedging arrangements,\nthe Underlying(s), taxation, the relevant currency or other matters – outside of the Issuer's control, the calculation agent may\ndetermine in its discretion to take one of the actions available to it in order to deal with the impact of such event on the Notes or\nthe Issuer or both. These actions may include (i) adjustment to the terms and conditions of the Notes, (ii) substitution of the\nUnderlying(s) and/or (iii) early redemption or exercise of the Notes. In performing these duties, the economic interests of the calculation\nagent and other affiliates of ours are potentially adverse to your interests as an investor in the Notes. Any such discretionary determination\nby the Issuer or the calculation agent could have a negative impact on the value of the Notes. We will not have any obligation to consider\nyour interests as a holder of the Notes in taking any action that might adversely affect the value of your Notes.

Uncertain\ntax treatment.

For\na discussion of the U.S. federal income tax consequences of your investment in a Note, please see the discussion under “U.S. Federal\nIncome Tax Considerations” herein, the discussion under “U.S. Federal Income Tax Considerations” in the accompanying\nprospectus supplement and the discussion under “Material Tax Considerations — Material U.S. Federal Income Tax Considerations”\nin the accompanying prospectus.

PS-9

ILLUSTRATIVE\nEXAMPLES

The\nfollowing table and examples are provided for illustrative purposes only and are hypothetical. They do not purport to be representative\nof every possible scenario concerning increases or decreases in the Final Value of any Underlying relative to its Initial Value. We cannot\npredict the Closing Price of any Underlying at any time during the term of the Notes, including the Final Valuation Date. The assumptions\nwe have made in connection with the illustrations set forth below may not reflect actual events. You should not take this illustration\nor these examples as an indication or assurance of the expected performance of any Underlying or the return on the Notes. The numbers\nappearing in the table below and following examples have been rounded for ease of analysis.

The\ntable and examples below illustrate the Payment at Maturity on a $1,000 investment in the Notes for a hypothetical range of Reference\nReturns of the Worst Performing Underlying from -100% to +100%. The following results are based solely on the assumptions outlined below.\nThe “Hypothetical Return on the Notes” as used below is the number, expressed as a percentage, that results from comparing\nthe Payment at Maturity per $1,000 Principal Amount to $1,000. The potential returns described below assume that the Notes are held to\nmaturity. The following table and examples are based on the following terms:

\n \n \n \n \n \n \n \n \n \n

Principal\n Amount:	$1,000
Upside\n Participation Rate:	150.00%
Hypothetical\n Initial Value of the Worst Performing Underlying:	$100.00

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

Hypothetical\n Final \n Value of the Worst \n Performing \nUnderlying	Hypothetical\n Reference Return \nof the Worst Performing \n Underlying	Hypothetical\n Payment at \n Maturity	Hypothetical\n Return on \n the Notes
$200.00	100.00%	$2,500.00	150.00%
$180.00	80.00%	$2,200.00	120.00%
$160.00	60.00%	$1,900.00	90.00%
$120.00	20.00%	$1,300.00	30.00%
$110.00	10.00%	$1,150.00	15.00%
$105.00	5.00%	$1,075.00	7.50%
$102.00	2.00%	$1,030.00	3.00%
$100.00⁽¹⁾	0.00%	$1,000.00	0.00%
$90.00	-10.00%	$900.00	-10.00%
$80.00	-20.00%	$800.00	-20.00%
$70.00	-30.00%	$700.00	-30.00%
$60.00	-40.00%	$600.00	-40.00%
$40.00	-60.00%	$400.00	-60.00%
$20.00	-80.00%	$200.00	-80.00%
$0.00	-100.00%	$0.00	-100.00%

\n\n

(1)

The hypothetical\n Initial Value of $100.00 used in these examples has been chosen for illustrative purposes\n only. The actual Initial Value of each Underlying is set forth on page PS-2 of this document.

PS-10

The\nfollowing examples indicate how the Payment at Maturity would be calculated with respect to a hypothetical $1,000 investment in the Notes\nassuming that the Notes are held to maturity.

Example\n1: The Reference Return of the Worst Performing Underlying Is 10.00%.

Because\nthe Reference Return of the Worst Performing Underlying is greater than zero, the Payment at Maturity would be $1,150.00 per $1,000 Principal\nAmount, calculated as follows:

$1,000\n+ ($1,000 × Reference Return of the Worst Performing Underlying × Upside Participation Rate)

=\n$1,000 + ($1,000 × 10.00% × 150.00%)

=\n$1,150.00

Example\n1 shows that the Notes provide a leveraged return if the Reference Return of the Worst Performing Underlying is positive.

Example\n2: The Reference Return of the Worst Performing Underlying Is -80.00%.

Because\nthe Reference Return of the Worst Performing Underlying is less than zero, the Payment at Maturity would be $200.00 per $1,000 Principal\nAmount, calculated as follows:

$1,000\n+ ($1,000 × Reference Return of the Worst Performing Underlying)

=\n$1,000 + ($1,000 × -80.00%)

=\n$200.00

Example\n2 shows that you are exposed on a 1-to-1 basis to any decrease in the value of the Worst Performing Underlying from its Initial Value.\nYou may lose up to 100% of your Principal Amount at maturity.

PS-11

DESCRIPTION\nOF THE REFERENCE ASSET

\n \n \n \n \n

Description\n of the QQQ

\n \n

The\nQQQ is a registered investment company that seeks to provide investment results that, before fees and expenses, correspond generally\nto the price and yield performance of the Nasdaq-100 Index^®. The Nasdaq-100 Index^® is designed to include\n100 of the largest domestic and international non-financial companies listed on U.S. Nasdaq-affiliated exchanges based on market capitalization.\nThe QQQ's investment adviser is Invesco Capital Management LLC and its inception date was March 9, 1999. Information about the QQQ that\nwas filed with the SEC can be located by reference to its CIK Code: 0001067839 through the SEC's website at http://www.sec.gov. Shares\nof the QQQ are listed on the Nasdaq Stock Market LLC under the ticker symbol “QQQ”.

Historical\n Performance of the QQQ

\n \n

The\n following graph sets forth the historical performance of the QQQ based on the daily historical closing prices from October 27, 2021\n through October 27, 2026. We obtained the closing prices below from Bloomberg L.P. (“Bloomberg”). We have not undertaken\n any independent review of, or made any due diligence inquiry with respect to, the information obtained from Bloomberg.

\n \n

$\"\"$

The\nhistorical prices of this Underlying should not be taken as an indication of its future performance, and no assurance can be given as\nto the Closing Price of this Underlying on the Final Valuation Date.

\n \n \n \n \n

Description\n of the SPY

\n \n

The\nSPY is a registered investment company that seeks to provide investment results that, before fees and expenses, correspond generally\nto the price and yield performance of the S&P 500^® Index. The S&P 500^® Index is designed to track\nthe performance of large-cap U.S. equities. The SPY's sponsor is PDR Services LLC and its inception date was January 22, 1993. Information\nabout the SPY that was filed with the SEC can be located by reference to its CIK Code: 0000884394 through the SEC's website at http://www.sec.gov.\nShares of the SPY are listed on the NYSE Arca, Inc. under the ticker symbol “SPY”.

Historical\n Performance of the SPY

\n \n

The\n following graph sets forth the historical performance of the SPY based on the daily historical closing prices from October 27, 2021\n through October 27, 2026. We obtained the closing prices below from Bloomberg. We have not undertaken any independent review of,\n or made any due diligence inquiry with respect to, the information obtained from Bloomberg.

\n \n

$\"\"$

PS-12

SUPPLEMENTAL\nPLAN OF DISTRIBUTION (CONFLICTS OF INTEREST)

We\nhave appointed MCMI, an affiliate of Marex, as the agent for the sale of the Notes. Pursuant to the terms of a distribution agreement,\nMCMI will purchase the Notes from Marex at the price to public less the underwriting discount set forth on the cover page of this pricing\nsupplement, for distribution to other registered broker-dealers or will offer the Notes directly to investors. MCMI has offered the Notes\nat the price to public set forth on the cover page of this document. MCMI will use the underwriting discount to pay selling concessions\nor fees (including custodial or clearing fees) to other registered broker-dealers.

An\naffiliate of Marex has paid or may pay in the future an amount to broker-dealers in connection with the costs of the continuing implementation\nof systems to support the Notes. We or one of our affiliates may pay a fee to one or more broker dealers for providing certain services\nwith respect to this offering, which may reduce the economic terms of the Notes to you.

In\naddition, MCMI or another of our affiliates or agents may use this pricing supplement in market-making transactions after the initial\nsale of the Notes, but is under no obligation to make a market in the Notes and may discontinue any market-making activities at any time\nwithout notice.

See\n“Supplemental Plan of Distribution (Conflicts of Interest)” on page S-61 in the prospectus supplement.

Delivery\nof the Notes will be made against payment for the Notes on the Original Issue Date set forth on the inside cover page of this document,\nwhich is more than one business day following the Trade Date. Under Rule 15c6-1 under the Securities Exchange Act of 1934, trades in\nthe secondary market generally are required to settle in one business day, unless the parties to that trade expressly agree otherwise.\nAccordingly, purchasers who wish to trade the Notes more than one business day prior to the Original Issue Date will be required to specify\nan alternate settlement cycle at the time of any such trade to prevent a failed settlement, and should consult their own advisors.

U.S.\nFEDERAL INCOME TAX CONSIDERATIONS

The\nU.S. federal income tax consequences of each holder’s investment in the Notes are uncertain. There are no Treasury Regulations,\npublished rulings or judicial decisions addressing the treatment for U.S. federal income tax purposes of securities with terms that are\nsubstantially the same as the Notes. By purchasing the Notes, each holder agrees (in the absence of a change in law, an administrative\ndetermination or a judicial ruling to the contrary) to treat each Note as a pre-paid executory contract for U.S. federal income tax purposes.\nIn the opinion of our counsel, Mayer Brown LLP, it would generally be reasonable to treat the Notes as pre-paid executory contracts in\nrespect of the Underlyings for U.S. federal income tax purposes.

In\naddition, subject to the discussion in the accompanying prospectus supplement regarding section 1260 of the Code, a U.S. Holder should\ngenerally recognize capital gain or loss upon redemption, sale or maturity or other taxable disposition of such holder’s Notes\nin an amount equal to the difference between the amount realized at such time and such holder’s tax basis in such Notes. In general,\na U.S. Holder’s tax basis in the Notes will equal the holder’s cost for the Notes. Such gain or loss should generally be\nlong-term capital gain or loss if a U.S. Holder has held the Notes for more than one year (otherwise such gain or loss should be short-term\ncapital gain or loss if held for one year or less). The deductibility of capital losses is subject to limitations. U.S. Holders should\nconsult their tax advisors regarding this risk.

The\nU.S. federal income tax consequences of a U.S. Holder’s investment in the Notes are uncertain and the Internal Revenue Service\ncould assert that the Notes should be taxed in a manner that is different from that described above. Please see the discussion in the\naccompanying prospectus supplement under “U.S. Federal Income Tax Considerations” and in particular the discussion under\n\"U.S. Federal Income Tax Considerations —U.S. Holders — Certain Notes Treated as a Put Option and a Deposit or an Executory\nContract — Certain Notes Treated as Executory Contracts” and the discussion in the accompanying prospectus under “Material\nTax Considerations — Material U.S. Federal Income Tax Considerations”.

Non-U.S.\nHolders should review the discussion in the accompanying prospectus supplement under “U.S. Federal Income Tax Considerations —\nNon-U.S. Holders” for a discussion of the U.S. federal income tax consequences applicable to Non-U.S. Holders.

A\n“dividend equivalent” payment is treated as a dividend from sources within the United States and such payments generally\nwould be subject to a 30% U.S. withholding tax if paid to a Non-U.S. Holder. Under Treasury Regulations, payments (including deemed payments)\nwith respect to equity-linked instruments (“ELIs”) that are “specified ELIs” may be treated as dividend equivalents\nif such specified ELIs reference an interest in an “underlying security,” which is generally any interest in an entity taxable\nas a corporation for U.S. federal income tax purposes if a payment with respect to such interest could give rise to a U.S. source dividend.\nHowever, IRS guidance provides that withholding on dividend equivalent payments will not apply to specified ELIs that are not delta-one\ninstruments and that are issued through 2028. We expect that the delta of the Notes will not be one, and therefore, we expect that Non-U.S.\nHolders should not be subject to withholding on dividend equivalent payments, if any, under the Notes. However, it is possible that the\nNotes could be treated as deemed reissued for U.S. federal income tax purposes upon the occurrence of certain events affecting an Underlying\nor the Notes, and following such occurrence the Notes could be treated as subject to withholding on dividend equivalent payments. Non-U.S.\nHolders that enter, or have entered, into other transactions in respect of an Underlying or the Notes should consult their tax advisors\nas to the application of the dividend equivalent withholding tax in the context of the Notes and their other transactions. If any payments\nare treated as dividend equivalents subject to withholding, we (or an applicable withholding agent) would be entitled to withhold taxes\nwithout being required to pay any additional amounts with respect to amounts so withheld.

PS-13

PROSPECTIVE\nPURCHASERS OF THE NOTES SHOULD CONSULT THEIR TAX ADVISORS AS TO THE TAX CONSEQUENCES OF THE ABOVE DESCRIBED CHARACTERIZATION OF THE NOTES\nAND ANY POSSIBLE ALTERNATIVE CHARACTERIZATIONS OF THE NOTES FOR U.S. FEDERAL INCOME TAX PURPOSES. PROSPECTIVE PURCHASERS OF NOTES SHOULD\nCONSULT THEIR TAX ADVISORS AS TO THE FEDERAL, STATE, LOCAL, AND OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION\nOF NOTES.

VALIDITY\nOF THE NOTES

In\nthe opinion of Mayer Brown LLP, as counsel to the Issuer, when this pricing supplement has been attached to, and duly notated on, the\nmaster global note that represents the Notes pursuant to the Indenture referred to in the prospectus, and such Notes have been delivered\nagainst payment as contemplated herein, such Notes will be valid, binding and enforceable obligations of the Issuer, entitled to the\nbenefits of the Indenture, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally,\nconcepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith,\nfair dealing and the lack of bad faith). This opinion is given as of the date hereof and is limited to the laws of the State of New York\nand the federal laws of the United States of America. Insofar as this opinion involves matters governed by Bermuda law, Mayer Brown LLP\nhas relied, with the Issuer’s permission, on the opinion of ASW Law Limited, dated as of July 6, 2026, filed as an exhibit to the\nPost-Effective Amendment No. 1 to the Registration Statement by the Issuer on July 6, 2026, and this opinion is subject to the same assumptions,\nqualifications and limitations as set forth in such opinion of ASW Law Limited. This opinion is subject to customary assumptions about\nthe Trustee’s authorization, execution and delivery of the Indenture and the genuineness of signatures and to such counsel’s\nreliance on the Issuer and other sources as to certain factual matters, all as stated in the legal opinion dated July 6, 2026, which\nhas been filed as Exhibit 5.2 to the Issuer’s Post-Effective Amendment No. 1 to the Registration Statement on Form F-3 dated July\n6, 2026.

PS-14

","zhKind","complete","MRX","公司与财报","融资","Nasdaq","aihot","/items/dq17z3m0wel8i2vste3q1xvkc","https://www.sec.gov/Archives/edgar/data/1997464/000110465926119461/0001104659-26-119461-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1793577600&sig=4b4ab60ed7bbc09f","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1793577600&sig=e088f7e0fbd3f246 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1793577600&sig=18c729d6e21bdeed 96w","changelogVersion","2026-10-01T08:00"]